Does long-term treatment with Doxil® predispose patients to oral cancer?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-012-0400-1.pdf
Reference5 articles.
1. Pujade-Lauraine E, Wagner U, Aavall-Lundquist E et al (2010) Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol 28:3323–3329
2. Gordon AN, Granai CO, Rose PG (2000) Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 18(17):3093–3100
3. Grenader T, Goldberg A, Gabizon A (2010) Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up? Anticancer Drugs 21(9):868–871
4. Andreopolou E, Gaiotti D, Kim E et al (2007) Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with re-current epithelial ovarian cancer. Ann Oncol 18(4):716–721
5. Cannon TL, Muggia F, Hirsch D, Andreopoulou EA, Kerr AR, DeLacure MD (2011) Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer. J Clin Oncol 29(suppl) (abstr 5557)
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is Systemic Immunosuppression a Risk Factor for Oral Cancer? A Systematic Review and Meta-Analysis;Cancers;2023-06-06
2. A case of tongue cancer manifesting from oral leukoplakia after long-term administration of pegylated liposomal doxorubicin;Oxford Medical Case Reports;2022-04-01
3. Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation;Cardiovascular Drugs and Therapy;2021-08-26
4. Drug-related cancers: Analyses of head and neck cases reported in the literature;Dental and Medical Problems;2021-06-25
5. Nanoporous Gold Monolith for High Loading of Unmodified Doxorubicin and Sustained Co-Release of Doxorubicin-Rapamycin;Nanomaterials;2021-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3